Healio

Moderate, high caffeine intake may protect against diabetic retinopathy

Please provide your email address to receive an email when new articles are posted on . Moderate and high caffeine intake was associated with reduced risk for diabetic retinopathy in patients with ...
Healio

Introduction and Definition

Type 1 diabetes (T1D) and type 2 diabetes (T2D) are metabolic diseases characterized by chronic hyperglycemia and impaired insulin function. Left untreated, both T1D and T2D can cause long-term ...
Business Wire

FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy

Diabetic retinopathy is the leading cause of blindness among working age adults and affects nearly 7.7 million people in the U.S. 1,2 The Lucentis 0.3 mg PFS is now the first syringe prefilled with an ...
FiercePharma

FDA Grants Priority Review for Genentech's Lucentis in Diabetic Retinopathy

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted to file the company's supplemental Biologics License ...
Business Wire

FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy, the Leading Cause of Blindness Among Working Age Adults in the United States

“Diabetic retinopathy is the leading cause of vision loss among working-aged adults in the U.S. between the ages of 20 and 74. We are very pleased that Lucentis is now FDA-approved to treat ...